This report addresses: Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listings for you to stay ahead of the curve Key Attributes: Market Dynamics Market driver analysis Increasing prevalence of chronic diseases such as diabetes and obesity Increasing R&D activities for developing novel therapeutics Formulation advancements of oral GLP-1 receptor agonists Increasing awareness about diagnosis and treatment options for diabetes Market restraint analysis Product failure Patent expiry of blockbuster drugs during the forecast period GLP-1 Receptor Agonist Market Analysis Tools Industry Analysis - Porter's PESTEL Analysis Pricing Analysis Pipeline Analysis Patent Expiry Analysis Companies Featured Eli Lilly and Company Sanofi Novo Nordisk A/S AstraZeneca Global GLP-1 Receptor Agonist Market Report Segmentation Product Outlook (Revenue, USD Million, 2021-2033) Ozempic Trulicity Mounjaro Wegovy Rybelsus Saxenda Victoza Zepbound Other Products Application Outlook (Revenue, USD Million, 2021-2033) Type 2 Diabetes Mellitus Obesity Route of administration Outlook (Revenue, USD Million, 2021-2033) Parenteral Oral Distribution Channel Outlook (Revenue, USD Million, 2021-2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional Outlook (Revenue, USD Million, 2021-2033) North America Europe Asia-Pacific Latin America Middle East and Africa (MEA) For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data
These B vitamins protect nerves against oxidative stress and damage, maintain myelin health, promote nerve cell survival, provide essential energy to nerve cells, and more
Its primary function is to help control blood sugar levels by acting like the GLP-1 hormone that our bodies naturally produce
Parthenolide phytosomes attenuated gentamicin-induced nephrotoxicity in rats via activation of Sirt-1, Nrf2, OH-1, and NQO1 axis
As a result, she suffered from severe gastrointestinal events, including severe vomiting, throwing up food hours after eating, stomach pain, gastrointestinal burning, hospitalizations for stomach issues and teeth falling out because of excessive vomiting, the lawsuit states
